AQR Capital Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.26M | Buy |
448,805
+180,508
| +67% | +$910K | ﹤0.01% | 1703 |
|
|
2025
Q1 | $1.74M | Buy |
268,297
+256,037
| +2,088% | +$1.66M | ﹤0.01% | 1686 |
|
|
2024
Q4 | $90K | Sell |
12,260
-4,662
| -28% | -$34.2K | ﹤0.01% | 2776 |
|
|
2024
Q3 | $127K | Buy |
16,922
+1,885
| +13% | +$14.1K | ﹤0.01% | 2632 |
|
|
2024
Q2 | $134K | Sell |
15,037
-11,022
| -42% | -$98.1K | ﹤0.01% | 2468 |
|
|
2024
Q1 | $264K | Buy |
26,059
+5,566
| +27% | +$56.4K | ﹤0.01% | 2173 |
|
|
2023
Q4 | $206K | Sell |
20,493
-69,382
| -77% | -$698K | ﹤0.01% | 2205 |
|
|
2023
Q3 | $842K | Sell |
89,875
-200,481
| -69% | -$1.88M | ﹤0.01% | 1660 |
|
|
2023
Q2 | $7.12M | Sell |
290,356
-47,316
| -14% | -$1.16M | 0.02% | 769 |
|
|
2023
Q1 | $7.86M | Buy |
337,672
+28,999
| +9% | +$675K | 0.02% | 723 |
|
|
2022
Q4 | $7.81M | Sell |
308,673
-44,060
| -12% | -$1.12M | 0.02% | 726 |
|
|
2022
Q3 | $6.8M | Buy |
352,733
+143,024
| +68% | +$2.76M | 0.02% | 748 |
|
|
2022
Q2 | $5.34M | Buy |
209,709
+100,139
| +91% | +$2.55M | 0.01% | 790 |
|
|
2022
Q1 | $2.82M | Buy |
+109,570
| New | +$2.82M | 0.01% | 1010 |
|
|
2021
Q4 | – | Sell |
-9,498
| Closed | -$413K | – | 2282 |
|
|
2021
Q3 | $413K | Buy |
+9,498
| New | +$413K | ﹤0.01% | 1935 |
|
|
2021
Q2 | – | Sell |
-12,111
| Closed | -$621K | – | 2304 |
|
|
2021
Q1 | $621K | Buy |
+12,111
| New | +$621K | ﹤0.01% | 1755 |
|
|
2020
Q4 | – | Sell |
-21,543
| Closed | -$740K | – | 2261 |
|
|
2020
Q3 | $740K | Buy |
+21,543
| New | +$740K | ﹤0.01% | 1562 |
|